Orchid Pharma Sees Notable Adjustment in Evaluation Amid Strong Market Performance Orchid Pharma, a midcap player in the Pharmaceuticals & Drugs industry, has recently experienced a significant adjustment in its evaluation by MarketsMOJO. The stock has been added to MarketsMOJO's list, reflecting a shift in its standing within the market. As of December 31, 2024, Orchid Pharma's price has approached its 52-week high, sitting just 1.09% below the peak of Rs 1850. The stock has demonstrated strong performance, outperforming its sector by 0.35% today. Additionally, Orchid Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend in its price action. Over the past year, Orchid Pharma has delivered an impressive return of 160.03%, significantly outpacing the Sensex, which recorded a performance of 8.01%. This remarkable growth underscores the company's strong market position and resilience in a competitive industry. As the stock continues to evolve, its recent revisions in score highlight the dynamic nature of its performance metrics.
Orchid Pharma has recently been added to MarketsMojo's list following a revision in its score, reflecting its strong market performance and upward momentum. The stock has outperformed its sector and is trading above key moving averages, showcasing impressive growth over the past year compared to the benchmark Sensex.
Orchid Pharma, a midcap player in the Pharmaceuticals & Drugs industry, has recently seen a notable adjustment in its evaluation by MarketsMOJO. The stock has been added to MarketsMOJO's list, reflecting a shift in its standing within the market. As of December 31, 2024, Orchid Pharma's price has approached its 52-week high, sitting just 1.09% below the peak of Rs 1850. The stock has demonstrated strong performance, outperforming its sector by 0.35% today. Additionally, Orchid Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend in its price action.
Over the past year, Orchid Pharma has delivered an impressive return of 160.03%, significantly outpacing the Sensex, which recorded a performance of 8.01%. This remarkable growth underscores the company's strong market position and resilience in a competitive industry. As the stock continues to evolve, its recent revisions in score highlight the dynamic nature of its performance metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
